???global.info.a_carregar???
Michael Stock. Completed the Licence in Medicine in 2003 by Albert-Ludwigs-Universität Freiburg Abteilung für Medizinische Soziologie and Licence in Biology in 1997 by Friedrich-Alexander-Universität Erlangen-Nürnberg - Campus Nürnberg. Is Postdoc in Department of Internal Medicine 3, University Hospital Erlangen, Germany. Published 33 articles in journals. Participates and/or participated as Principal investigator in 1 project(s).
Identification

Personal identification

Full name
Michael Stock

Citation names

  • Stock, Michael

Author identifiers

Ciência ID
8A1E-96C5-2F55
ORCID iD
0000-0002-3322-0961
Education
Degree Classification
1998 - 2003
Concluded
Medicine (Licence)
Albert-Ludwigs-Universität Freiburg Abteilung für Medizinische Soziologie, Germany
1992 - 1997
Concluded
Biology (Licence)
Friedrich-Alexander-Universität Erlangen-Nürnberg - Campus Nürnberg, Germany
Affiliation

Science

Category
Host institution
Employer
2010 - Current Postdoc (Research) Department of Internal Medicine 3, University Hospital Erlangen, Germany, Germany
2005 - 2010 Postdoc (Research) Department of Experimental Medicine I, University of Erlangen-Nuremberg, Germany, Germany
2003 - 2005 Postdoc (Research) Albert-Ludwigs-Universität Freiburg Abteilung für Medizinische Soziologie, Germany
Projects

Grant

Designation Funders
2019 - 2022 Die Rolle von Wif-1 und weiterer sezernierter Wnt-Inhibitoren bei der Kontrolle von Wnt-Signalwegen während der Osteophytenbildung
DFG
Principal investigator
University Hospital Erlangen, Germany
Ongoing
2017 - 2018 Charakterisierung der Aggrekanasehemmung durch Ucma bei der Arthrose
STAEDTLER Stiftung
Principal investigator
University Hospital Erlangen, Germany
Concluded
2014 - 2017 Die Aufklärung des Knorpelproteins Ucma in degenerativen und entzündlichen Gelenkerkrankungen
DFG
Principal investigator
University Hospital Erlangen, Germany
Concluded
2013 - 2014 Hedgehog-Signale und der zelluläre Ursprung pathologischer Knochenneubildung bei entzündlichen Gelenk-erkrankungen
ELAN
Principal investigator
University Hospital Erlangen, Germany
Concluded
2007 - 2010 Aufklärung von Funktion und Regulation des extrazellulären Knorpelproteins RIK111
DFG Grant
Principal investigator
Concluded
2007 - 2010 Die Rolle des Wnt-Inhibitory Factors Wif-1 in der Entstehung und Stablisierung der Gelenkoberfläche
IZKF
Principal investigator
University Hospital Erlangen, Germany
Concluded
Outputs

Publications

Journal article
  1. Seuffert, Fritz; Weidner, Daniela; Baum, Wolfgang; Schett, Georg; Stock, Michael. "Upper zone of growth plate and cartilage matrix associated protein protects cartilage during inflammatory arthritis". Arthritis Research & Therapy 20 1 (2018): http://dx.doi.org/10.1186/s13075-018-1583-2.
    Published • 10.1186/s13075-018-1583-2
  2. Stock, Michael. "Defects in chondrocyte maturation and secondary ossification in mouse knee joint epiphyses due to Snorc deficiency.". Osteoarthritis and cartilage (2017): http://europepmc.org/abstract/med/28323137.
    10.1016/j.joca.2017.03.010
  3. Stock, Michael. "Corrigendum to "Fc-gamma receptors are not involved in cartilage damage during experimental osteoarthritis" [Osteoarthritis Cartilage 23 (2015) 1221-1225].". Osteoarthritis and cartilage (2017): http://europepmc.org/abstract/med/27865755.
    10.1016/j.joca.2016.11.003
  4. Stock, Michael. "A Dual Role of Upper Zone of Growth Plate and Cartilage Matrix-Associated Protein in Human and Mouse Osteoarthritic Cartilage: Inhibition of Aggrecanases and Promotion of Bone Turnover.". Arthritis & rheumatology (Hoboken, N.J.) (2017): http://europepmc.org/abstract/med/28086000.
    10.1002/art.40042
  5. Stock, Michael. "Inhibition of Notch1 promotes hedgehog signalling in a HES1-dependent manner in chondrocytes and exacerbates experimental osteoarthritis.". Annals of the rheumatic diseases (2016): http://europepmc.org/abstract/med/26851274.
    10.1136/annrheumdis-2015-208420
  6. Stock, Michael. "Rsk2 controls synovial fibroblast hyperplasia and the course of arthritis.". Annals of the rheumatic diseases (2016): http://europepmc.org/abstract/med/25414238.
    10.1136/annrheumdis-2014-205618
  7. Stock, Michael. "Inhibition of Osteoarthritis by Adipose-Derived Stromal Cells Overexpressing Fra-1 in Mice.". Arthritis & rheumatology (Hoboken, N.J.) (2016): http://europepmc.org/abstract/med/26361381.
    10.1002/art.39425
  8. Stock, Michael. "Fc-gamma receptors are not involved in cartilage damage during experimental osteoarthritis.". Osteoarthritis and cartilage (2015): http://europepmc.org/abstract/med/25748082.
    10.1016/j.joca.2015.02.019
  9. Stock, Michael. "Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage.". Biology open (2015): http://europepmc.org/abstract/med/25882555.
    10.1242/bio.201411031
  10. Stock, Michael. "Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.". Annals of the rheumatic diseases (2013): http://europepmc.org/abstract/med/23666928.
    10.1136/annrheumdis-2013-203345
  11. Stock, Michael. "Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor a-mediated experimental arthritis.". Arthritis and rheumatism (2013): http://europepmc.org/abstract/med/23784913.
    10.1002/art.38054
  12. Stock, Michael. "PPARß/d governs Wnt signaling and bone turnover.". Nature medicine (2013): http://europepmc.org/abstract/med/23542786.
    10.1038/nm.3146
  13. Stock, Michael. "RSK2 protects mice against TNF-induced bone loss.". Journal of cell science (2012): http://europepmc.org/abstract/med/22344264.
    10.1242/jcs.096008
  14. Stock, Michael. "The Wnt antagonist Wif-1 interacts with CTGF and inhibits CTGF activity.". Journal of cellular physiology (2012): http://europepmc.org/abstract/med/21928342.
    10.1002/jcp.22957
  15. Stock, Michael. "Ucma is not necessary for normal development of the mouse skeleton.". Bone (2012): http://europepmc.org/abstract/med/22155508.
    10.1016/j.bone.2011.11.017
  16. Stock, Michael. "Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis.". Annals of the rheumatic diseases (2012): http://europepmc.org/abstract/med/22233602.
    10.1136/ard.2010.148262
  17. Stock, Michael. "R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway.". Arthritis and rheumatism (2010): http://europepmc.org/abstract/med/20506554.
    10.1002/art.27496
  18. Stock, Michael. "Stable subclones of the chondrogenic murine cell line MC615 mimic distinct stages of chondrocyte differentiation.". Journal of cellular biochemistry (2009): http://europepmc.org/abstract/med/19670270.
    10.1002/jcb.22290
  19. Stock, Michael. "Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis.". Journal of cell science (2009): http://europepmc.org/abstract/med/19755491.
    10.1242/jcs.048926
  20. Stock, Michael. "Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis.". The Journal of biological chemistry (2008): http://europepmc.org/abstract/med/18156182.
    10.1074/jbc.m702792200
  21. Stock, Michael. "Ucma--A novel secreted factor represents a highly specific marker for distal chondrocytes.". Matrix biology : journal of the International Society for Matrix Biology (2008): http://europepmc.org/abstract/med/17707622.
    10.1016/j.matbio.2007.07.004
  22. Stock, Michael. "Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.". Journal of leukocyte biology (2006): http://europepmc.org/abstract/med/17000900.
    10.1189/jlb.0106005
  23. Stock, Michael. "Twisted gastrulation modulates bone morphogenetic protein-induced collagen II and X expression in chondrocytes in vitro and in vivo.". The Journal of biological chemistry (2006): http://europepmc.org/abstract/med/16905550.
    10.1074/jbc.m603419200
  24. Stock, Michael. "Gene deregulation in gastric cancer.". Gene (2005): http://europepmc.org/abstract/med/16154715.
    10.1016/j.gene.2005.06.026
  25. Stock, Michael. "Control of RUNX2 isoform expression: the role of promoters and enhancers.". Journal of cellular biochemistry (2005): http://europepmc.org/abstract/med/15838892.
    10.1002/jcb.20471
  26. Stock, Michael. "Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.". Oncogene (2004): http://europepmc.org/abstract/med/15489901.
    10.1038/sj.onc.1208042
  27. Stock, Michael. "Simplified method for gene targeting vector construction.". BioTechniques (2004): http://europepmc.org/abstract/med/15560127.
  28. Stock, Michael. "Identification of novel genes of the bone-specific transcription factor Runx2.". Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2004): http://europepmc.org/abstract/med/15190888.
    10.1359/jbmr.2004.19.6.959
  29. Stock, Michael. "Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemia.". Leukemia (2003): http://europepmc.org/abstract/med/12886262.
    10.1038/sj.leu.2403007
  30. Stock, Michael. "Upstream and downstream targets of RUNX proteins.". Journal of cellular biochemistry (2003): http://europepmc.org/abstract/med/12682904.
    10.1002/jcb.10491
  31. Stock, Michael. "Expression of galectin-3 in skeletal tissues is controlled by Runx2.". The Journal of biological chemistry (2003): http://europepmc.org/abstract/med/12604608.
    10.1074/jbc.m207631200
  32. Stock, Michael. "Genomic characterization of the RUNX2 gene of Fugu rubripes.". Gene (2002): http://europepmc.org/abstract/med/12095689.
    10.1016/s0378-1119(02)00592-9
  33. Stock, Michael. "Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.". American journal of human genetics (1999): http://europepmc.org/abstract/med/10521292.
    10.1086/302622